Sequana Medical H.C. Wainwright Conference 2022

Sequana Medical presented at the H.C. Wainwright Global Investment Conference in May 2022, showcasing its alfapump® system for treating diuretic-resistant fluid overload and ascites. The company develops innovative medical devices including the alfapump® system currently in clinical investigation in the US and Canada, and DSR® therapy in pre-clinical development.